LY4268989: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
29
US states with sites
34
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Ulcerative Colitis | 2 |
| Ulcerative Colitis (UC) | 1 |
| Ulcerative Colitis, Active Moderate | 1 |
| Ulcerative Colitis, Active Severe | 1 |
Recruiting trials involving LY4268989
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Common questions
How many recruiting trials involve LY4268989?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.